Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program

Adrienne L. Morey*, Belinda Brown, Gelareh Farshid, Stephen B. Fox, Glenn D. Francis, Glenda McCue, Vita von Neumann-Cosel, Michael Bilous

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology